Recent Finacing
Recent Raise
EpiTherapeutics develops small-molecule epigenetic inhibitors targeting enzymes that regulate transcriptional activation in cancer, conducting drug discovery in collaboration with Prof. Kristian Helin’s lab at BRIC in Copenhagen.
Focus Areas
Recent Investors
Funding round
Investors
